What are gallbladder hydrops and gallbladder empyema, and how are they diagnosed and managed?

Gallbladder Hydrops and Empyema: Definitions, Diagnosis, and Management

Definitions

Gallbladder hydrops (mucocele) is a distended gallbladder filled with clear, mucous-like inspissated bile caused by cystic duct obstruction, typically from an impacted stone. 1, 2 The obstruction leads to reabsorption of bile components (bilirubin, bile salts, cholesterol) and continued mucous secretion by the gallbladder mucosa, resulting in a tense, distended organ containing sterile "white bile" that is roughly isotonic with blood. 3

Gallbladder empyema is a severe complication of acute cholecystitis characterized by pus accumulation within the gallbladder lumen due to bacterial overgrowth and tissue necrosis. 4, 5 This represents progression from simple cholecystitis when persistent cystic duct obstruction leads to venous congestion, pressure necrosis, and suppurative infection. 4

Clinical Presentation

Hydrops

• Most patients are asymptomatic and diagnosed incidentally on imaging 1
• When symptomatic: right upper quadrant pain, palpable mass, or atypical abdominal symptoms 1, 2
• Absence of fever and systemic signs distinguishes hydrops from empyema 3

Empyema

• Right upper quadrant tenderness and Murphy's sign 6
• Fever and systemic illness 6, 4
• Critical pitfall: Presentation may be indolent with scanty physical signs, leading to delayed diagnosis and increased morbidity/mortality 5
• Palpable gallbladder mass suggests complicated disease 6

Diagnostic Approach

Imaging Modalities

Ultrasound is the investigation of choice for suspected gallbladder pathology. 6 Key findings include:

• Distended gallbladder with thickened, edematous wall 6
• Impacted stone in cystic duct or gallbladder neck 6, 3
• Pericholecystic fluid 6
• Positive sonographic Murphy's sign 6

CT with IV contrast provides superior detail for complicated cases, demonstrating:

• Gallbladder wall defects (if perforation present) 6
• Pericholecystic collections 6
• Extent of inflammation 6

Critical distinction: A thickened gallbladder wall from collateral veins (portal cholangiopathy) must be differentiated from true cholecystitis. 6

Prognostic Factors for Severe Disease

Risk factors for empyema and complicated cholecystitis include: 4

• Gallbladder wall thickness >4mm
• Male gender
• Elevated white blood cell count
• Diabetes mellitus

Management

Hydrops

Early laparoscopic cholecystectomy is the definitive treatment for symptomatic hydrops. 6 The gallbladder is typically under high pressure (average 61.5 cm saline, range 15-115 cm) and requires careful decompression during surgery. 3

• One-shot antibiotic prophylaxis if early intervention performed 6
• No postoperative antibiotics needed for uncomplicated cases 6

Empyema (Complicated Cholecystitis)

Immediate surgical intervention is mandatory to reduce morbidity and mortality. 6, 7

Surgical Strategy

Laparoscopic cholecystectomy with open conversion as alternative 6

Antibiotic therapy duration based on patient status:

• Immunocompetent, non-critically ill: 4 days if adequate source control 6
• Immunocompromised or critically ill: Up to 7 days based on clinical response and inflammatory markers 6
• Beyond 7 days of persistent infection: Warrants diagnostic investigation for complications 6

Antibiotic Regimens

For non-critically ill, immunocompetent patients with adequate source control: 6

• Amoxicillin/clavulanate 2g/0.2g q8h
• If beta-lactam allergy: Eravacycline 1 mg/kg q12h OR Tigecycline 100 mg loading dose then 50 mg q12h

For critically ill or immunocompromised patients: 6

• Piperacillin/tazobactam 6g/0.75g loading dose then 4g/0.5g q6h or 16g/2g continuous infusion
• If beta-lactam allergy or high risk for ESBL organisms: Ertapenem 1g q24h OR Eravacycline 1mg/kg q12h

Alternative for High-Risk Surgical Candidates

Percutaneous cholecystostomy is safe and effective for critically ill patients with multiple comorbidities who are unfit for surgery. 6, 7 However, this is inferior to cholecystectomy in terms of major complications and should only be used when surgery is contraindicated. 6

• Antibiotic therapy for 4 days post-drainage 6
• Consider delayed cholecystectomy when patient stabilizes 7

Critical Complications

Gallbladder perforation occurs in 2-11% of acute cholecystitis cases with mortality of 12-16%. 6, 7

Early diagnosis and immediate surgical intervention substantially decrease morbidity, mortality, ICU admission rates, and hospital length of stay. 6, 7 Delayed intervention is associated with significantly worse outcomes. 6, 7

Perforation Types:

• Type I (acute): Free perforation with generalized peritonitis—requires immediate cholecystectomy with extensive peritoneal lavage 6, 7
• Type II (subacute): Pericholecystic abscess with localized peritonitis 6
• Type III (chronic): Cholecystoenteric fistula 6